Cargando…
Association Between HbA1c Levels and Diabetic Peripheral Neuropathy: A Case–Control Study of Patients with Type 2 Diabetes Using Claims Data
BACKGROUND: Evidence on the efficacy of glycemic control for diabetic peripheral neuropathy (DPN) is limited in patients with type 2 diabetes mellitus. Despite the known relationship between hemoglobin A1c (HbA1c) and DPN, the parameters (e.g., mean values or variability) that play an important role...
Autores principales: | Nozawa, Kazutaka, Ikeda, Masato, Kikuchi, Shogo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392831/ https://www.ncbi.nlm.nih.gov/pubmed/35725984 http://dx.doi.org/10.1007/s40801-022-00309-3 |
Ejemplares similares
-
HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018) -
Glycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy
por: Casadei, Giulia, et al.
Publicado: (2021) -
HbA1C Variability Is Strongly Associated With the Severity of Peripheral Neuropathy in Patients With Type 2 Diabetes
por: Lai, Yun-Ru, et al.
Publicado: (2019) -
The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c
por: Xu, Feng, et al.
Publicado: (2014) -
HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes
por: Pinto, M. V., et al.
Publicado: (2020)